Cargando…
Drug-Induced Eosinophilic Pneumonia as an Adverse Event of Abemaciclib
In 2020, a 45-year-old woman was started on fulvestrant and abemaciclib therapy to treat breast cancer which had recurred in her left breast after surgery. We were able to control her cancer using this treatment; however, the ground-glass opacity in the lower lobe of her right lung expanded, along w...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888010/ https://www.ncbi.nlm.nih.gov/pubmed/35251813 http://dx.doi.org/10.7759/cureus.21741 |